Kinnate Biopharma
1 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| A Study to Evaluate KIN-3248 in Participants With Advanced Tumors Harboring FGFR2 and//or FGFR3 Gene Alterations (NCT05242822) | Kinnate Biopharma | 2022-03-29 |
Track Kinnate Biopharma automatically
Every clearance here is in the API, with alerts when new ones post.